Traitement en amont

Upstream processing is the initial stage of biomanufacturing where living cells are cultivated to produce biological products such as therapeutic proteins, vaccines, and enzymes. It encompasses host organism selection, genetic optimization, media development, and cell cultivation in bioreactors under tightly controlled environmental conditions until the desired biomass or product concentration is achieved.

Growth media are tailored by adjusting carbon sources like glucose, nitrogen sources such as ammonium salts, vitamins, and trace elements to meet the nutritional requirements of the production organism. Optimized ratios of these components enhance cell growth and product yield. Designing growth media for bioreactors requires balancing these nutrients to support high-density cultures while maintaining sterility and product quality.

The host organism determines product yield, stability, and quality. Common hosts include Escherichia coli, Saccharomyces cerevisiae, Chinese hamster ovary cells, and Pichia pastoris. Genetically engineered hosts are often designed to express desired products with high efficiency. Selecting the appropriate host directly impacts the success and cost-effectiveness of the entire biomanufacturing process.

Large-scale bioreactors maintain precise control over pH, temperature, dissolved oxygen, and agitation rates. Automated systems equipped with sensors continuously monitor these parameters and make real-time adjustments to ensure optimal growth conditions. For recombinant systems, inducers like IPTG regulate gene expression at specific growth phases to achieve high cell density and consistent product quality.

Seed culture expansion begins with laboratory-scale shake flasks or small bioreactors and progressively scales up through a series of seed bioreactors to develop a robust inoculum for production-scale bioreactors. This sequential scaling ensures consistent growth conditions and maintains culture viability. Once sufficient biomass is achieved, the inoculum is transferred to larger bioreactors for fermentation.

Once the desired biomass or product concentration is achieved at the end of fermentation, downstream processing is initiated for product recovery and purification. This phase extracts the biological product from the culture broth and prepares it for final formulation and use. Downstream processing transforms the fermentation output into a purified, therapeutically viable product.

Sterility and contamination control are critical at every stage to ensure a pure and productive culture. Maintaining sterile conditions prevents unwanted microorganisms from competing with the production organism for nutrients and potentially degrading the target product. Proper sterilization of media, equipment, and bioreactor design and operational system components ensures culture integrity and product quality throughout cultivation.